Azaprocin

Error creating thumbnail:

Azaprocin is a potent opioid analgesic drug that was developed in the 1970s. It is a member of the benzomorphan class of opioids and is known for its high potency and rapid onset of action.

Chemical Structure and Properties

Azaprocin is chemically classified as a benzomorphan derivative. Its chemical structure is characterized by the presence of a benzene ring fused to a morphinan skeleton. The molecular formula of Azaprocin is C_18H_23NO_2, and it has a molecular weight of 285.38 g/mol.

Pharmacology

Azaprocin acts primarily as an agonist at the mu-opioid receptor (MOR), which is responsible for its analgesic effects. It also has some affinity for the kappa-opioid receptor (KOR) and the delta-opioid receptor (DOR), although its activity at these receptors is less pronounced. The activation of these receptors leads to the inhibition of adenylate cyclase, reduction in the release of neurotransmitters such as substance P, and modulation of ion channels, which collectively contribute to its analgesic properties.

Medical Use

Azaprocin is used in the management of moderate to severe pain. Due to its high potency, it is often reserved for cases where other opioid analgesics are ineffective. It is administered via various routes, including oral, intravenous, and intramuscular.

Side Effects

As with other opioids, Azaprocin can cause a range of side effects. Common side effects include:

• Nausea
• Vomiting
• Constipation
• Drowsiness
• Respiratory depression

Addiction and Abuse Potential

Azaprocin, like other opioids, has a high potential for addiction and abuse. Prolonged use can lead to the development of tolerance, physical dependence, and withdrawal symptoms upon cessation.

Legal Status

The legal status of Azaprocin varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction.

See Also

• Opioid
• Analgesic
• Benzomorphan
• Mu-opioid receptor
• Kappa-opioid receptor
• Delta-opioid receptor

External Links

‎